Wexford Capital

Sailfish Royalty Corp. is a company focused on acquiring gold and silver royalty and streaming agreements across the Americas. Incorporated in 2014 and headquartered in Road Town, British Virgin Islands, Sailfish holds significant interests in several mining projects. Notably, it owns a 3.5% royalty on revenues from the Tocantinzinho gold project in Brazil as well as a gold stream agreement that provides a 3% net smelter return on the San Albino gold project in Nicaragua. Additionally, the company has a royalty interest of up to 3% on the Spring Valley gold project in Nevada. Through these assets, Sailfish aims to generate yield from the growing demand for precious metals.

Shape Memory Medical Inc is a medical device company located in Santa Clara, California, focused on creating innovative therapeutic solutions for the peripheral vascular, cardiovascular, and neurovascular markets. The company specializes in utilizing Shape Memory Polymer (SMP) technology, which was originally developed at Texas A&M University and Lawrence Livermore National Laboratory. Shape Memory Medical is notable for being the first to introduce an FDA-cleared medical device incorporating SMP technology specifically for the vascular market, thereby enhancing the capabilities of physicians in patient care. The team at Shape Memory Medical possesses significant expertise in SMP foam technology and the commercialization of medical devices, positioning the company as a leader in its field.

Bonterra Resources Inc. is a Canadian gold exploration company focused on the acquisition, exploration, and evaluation of mineral properties primarily in the province of Quebec. Incorporated in 2007 and headquartered in Val-d'Or, the company has established a significant land position of approximately 35,000 hectares within the Urban Barry Camp, situated in the mining-friendly Abitibi Greenstone Belt. Bonterra's key projects include the Gladiator Deposit, the Moroy Deposit, and the Barry Deposit. Notably, it operates the only permitted gold mill in the region, facilitating its exploration and mining activities. The company's operations encompass both mineral exploration and mining site care and maintenance, positioning it as a significant player in the Canadian gold sector.

Viseon, Inc. is a medical device company based in Irvine, California, dedicated to advancing Minimally Invasive Spine Surgery (MISS) through innovative technology. Established in 2017 as a spin-out from Rebound Therapeutics Corporation, Viseon has developed the Voyant technology, which serves as a single-use, disposable alternative to traditional surgical microscopes, endoscopes, and loupes. This technology enhances surgical visualization by projecting the operative field onto a high-definition flat panel display, facilitating both in-room and remote observation. Viseon has made significant strides in product development, assembling a world-class Scientific Advisory Board and securing 13 patents to strengthen its intellectual property. The company is poised to begin human-use studies following a series of pre-clinical trials, aiming to improve procedural and clinical outcomes in spine surgery.

AZTherapies, Inc. is a biopharmaceutical company based in Boston, Massachusetts, focused on discovering, developing, and commercializing innovative therapies for neurodegenerative diseases, including Alzheimer's, stroke, ALS, and Parkinson's disease. Established in 2011, the company is advancing a clinical-stage pipeline of small molecule drugs designed to address the underlying mechanisms of these conditions, particularly neuroinflammation and the aggregation of amyloid-beta proteins. Its lead candidate, ALZT-OP1, employs a multi-modal approach to potentially halt or slow the progression of Alzheimer's disease, with the Phase 3 COGNITE trial fully enrolled. In addition to Alzheimer's, AZTherapies is also progressing treatments for cognitive impairment following strokes and other related disorders, aiming to enhance the quality of life for aging populations with limited therapeutic options.

Specialty Renal Products, a subsidiary of Nephros, is focused on the development of medical device products for patients with renal disease, including a hemodiafiltration system for the treatment of patients with ESRD.SRP intends to develop and market a filtration system for use in conjunction with the disposable tubing circuit sets used in treatments that provide continuous renal replacement therapy (CRRT). The system will apply to patients who present in the intensive care unit with acute kidney injury (AKI). CRRT allows the clinician the ability to manage unstable AKI patients by offering slower ultrafiltration and solute removal. Some advantages with performing CRRT continuously (24 hours per day) include improved hemodynamic tolerance and more control over the total volumes given and removed from unstable AKI patients.

Viseon, Inc. is a medical device company based in Irvine, California, dedicated to advancing Minimally Invasive Spine Surgery (MISS) through innovative technology. Established in 2017 as a spin-out from Rebound Therapeutics Corporation, Viseon has developed the Voyant technology, which serves as a single-use, disposable alternative to traditional surgical microscopes, endoscopes, and loupes. This technology enhances surgical visualization by projecting the operative field onto a high-definition flat panel display, facilitating both in-room and remote observation. Viseon has made significant strides in product development, assembling a world-class Scientific Advisory Board and securing 13 patents to strengthen its intellectual property. The company is poised to begin human-use studies following a series of pre-clinical trials, aiming to improve procedural and clinical outcomes in spine surgery.

Shape Memory Medical Inc is a medical device company located in Santa Clara, California, focused on creating innovative therapeutic solutions for the peripheral vascular, cardiovascular, and neurovascular markets. The company specializes in utilizing Shape Memory Polymer (SMP) technology, which was originally developed at Texas A&M University and Lawrence Livermore National Laboratory. Shape Memory Medical is notable for being the first to introduce an FDA-cleared medical device incorporating SMP technology specifically for the vascular market, thereby enhancing the capabilities of physicians in patient care. The team at Shape Memory Medical possesses significant expertise in SMP foam technology and the commercialization of medical devices, positioning the company as a leader in its field.

Rebound Therapeutics Corp. is a medical device company based in Irvine, California, focused on developing single-use, disposable devices that enhance access, imaging, and illumination during minimally invasive surgical procedures. Established in 2015, the company has made significant strides in product development, creating a unique range of devices aimed at improving procedural and clinical outcomes in various surgical fields, including neurosurgery, spine, orthopedic, thoracic, and general abdominal surgeries. Rebound Therapeutics has assembled a distinguished Scientific Advisory Board of leading physicians in minimally invasive surgery and has filed 14 patents to protect its innovative technologies. The company is also preparing for initial human-use trials following a series of successful pre-clinical studies. As of September 2019, Rebound operates as a subsidiary of Integra LifeSciences Holdings Corporation.

ElMindA is an Israeli company based in Herzliya, with an additional office in Glenview, Illinois, founded in 2006. It specializes in developing a tool for diagnosing, monitoring, and treating brain-related disorders using its proprietary Brain Network Activation (BNA) technology. This technology integrates electroencephalography, event-related potential testing, machine learning, advanced algorithms, and large-population databases to visualize and evaluate the complex neuro-physiological interconnections of the human brain in action. By capturing detailed electrophysiological patterns related to specific functions evoked by repeatable tasks, BNA creates high-resolution, three-dimensional representations of functional neural pathways. These representations help assess brain function and health, aiding in the management of conditions such as mild traumatic brain injury, major depressive disorder, Parkinson’s disease, multiple sclerosis, ADHD, and mild cognitive impairment.

Vantage Sports, Inc. is a data and video analytics company based in Bellevue, Washington, incorporated in 2011. It provides a comprehensive data collection platform that revolutionizes how sports teams, media, and fans gather, analyze, and utilize performance data. Focusing primarily on the NBA, Vantage Sports goes beyond traditional statistical categories to offer in-depth insights into athlete and franchise performance. The platform enables clients to access extensive analytics, facilitating a deeper understanding of player statistics and enhancing decision-making processes within sports organizations. Vantage Sports operates as a subsidiary of Competitive Analytics Consulting LLC, striving to create innovative tools for data analysis in the sports industry.

DIG operates a restaurant chain focused on providing fresh, locally sourced meals. With an emphasis on seasonal ingredients, the restaurants offer organic dishes prepared from scratch using vegetables, whole grains, and naturally-raised meats. The company collaborates closely with trusted farmers and producers to ensure high-quality ingredients. Customers can enjoy healthy, expertly crafted meals at an affordable average price, with the convenience of online ordering and direct table service.

OptiScan Biomedical Corporation, founded in 1994 and located in Hayward, California, specializes in developing bedside blood monitoring systems for critically ill patients in intensive care units (ICUs). The company's flagship product, the OptiScanner 5000, is an automated glucose monitoring platform that utilizes spectroscopy technology to measure plasma glucose levels directly, eliminating the need for calibration. This system enables healthcare providers to rapidly detect changes in glucose levels, thus supporting better management of critically ill patients' health.

Sophono, Inc. is a medical device manufacturer based in Boulder, Colorado, specializing in magnetic bone conduction hearing devices designed for patients with conductive hearing loss, mixed hearing loss, and single-sided deafness. Founded in 2009, the company produces innovative products such as the Alpha 1 and Alpha 2 MPO hearing devices, which utilize a unique abutment-free design that allows for the implantation of sound processors beneath the skin. These devices aim to provide effective solutions for individuals experiencing severe to profound hearing impairment. Sophono sells its products through clinics and operates as a subsidiary of Medtronic plc as of 2015.

Invuity, Inc. is a medical technology company based in San Francisco, California, specializing in the development and marketing of surgical devices designed for enhanced visualization during minimally invasive procedures. Founded in 2004, the company utilizes advanced photonics technology to create illuminated surgical devices that provide surgeons with improved illumination and direct visualization of surgical cavities. Its product offerings include various illuminated retractor systems and handheld illuminators suitable for multiple surgical specialties, such as orthopedics, gynecology, and plastic surgery. Notable products include the Eikon LT illuminated retractor system, the PhotonBlade illuminator, and the BriteField Port System, all designed to enhance precision, efficiency, and safety during surgical procedures. Invuity sells its devices through a combination of direct sales representatives, independent agents, and directly to hospitals and surgeons. The company was previously known as Spotlight Surgical, Inc. and adopted its current name in 2007. As of 2018, Invuity operates as a subsidiary of Stryker Corporation.

Invuity, Inc. is a medical technology company based in San Francisco, California, specializing in the development and marketing of surgical devices designed for enhanced visualization during minimally invasive procedures. Founded in 2004, the company utilizes advanced photonics technology to create illuminated surgical devices that provide surgeons with improved illumination and direct visualization of surgical cavities. Its product offerings include various illuminated retractor systems and handheld illuminators suitable for multiple surgical specialties, such as orthopedics, gynecology, and plastic surgery. Notable products include the Eikon LT illuminated retractor system, the PhotonBlade illuminator, and the BriteField Port System, all designed to enhance precision, efficiency, and safety during surgical procedures. Invuity sells its devices through a combination of direct sales representatives, independent agents, and directly to hospitals and surgeons. The company was previously known as Spotlight Surgical, Inc. and adopted its current name in 2007. As of 2018, Invuity operates as a subsidiary of Stryker Corporation.

Ellipse Technologies is a privately-held medical device company based in California that specializes in the development of implantable remote control technology for spinal and orthopedic applications. The company designs and commercializes innovative devices aimed at treating a wide range of spinal deformities and orthopedic trauma, including fracture management. Its flagship products, the MAGEC MAGnetic Expansion Control System and the PRECICE System, utilize advanced, non-invasive technologies that allow for remote adjustments by physicians through an external magnetic field. These devices are designed to restore proper anatomical position and alignment, improving patient outcomes in the management of spinal and long-bone abnormalities.

Reverse Medical is a commercial-stage medical device company dedicated to the development of innovative solutions for neurovascular disorders, particularly in the management of acute ischemic strokes. The company specializes in creating embolic protection systems designed to enhance the revascularization process for patients experiencing these critical conditions. By concentrating on endovascular treatment options, Reverse Medical aims to improve patient outcomes and streamline interventions for stroke care, positioning itself as a key player in the medical technology sector.

International Battery (IB) is a green technology company providing environmentally friendly, large format, rechargeable lithium-ion cells and batteries — designed, developed and manufactured in the USA. IB provides next generation cell chemistries, electronics and advanced packaging technologies, broad design experience, and offers total solutions for rechargeable battery applications. There batteries can be used in a wide range of vehicular, industrial and military applications.

Infinia Corporation is a solar energy technology company that specializes in the development of innovative power generation systems. The company's flagship product, the PowerDish, is a proprietary solar power generation device that efficiently converts solar energy into electricity. Infinia also provides micro combined heat and power systems targeted at residential energy consumers, as well as solar and biomass-powered electric generators designed for various applications, including deep space missions and remote power needs. The PowerDish is aimed at energy asset developers, utilities, and commercial companies involved in large-scale solar projects, with a global launch anticipated to have begun in late 2010.

Infinia Corporation is a solar energy technology company that specializes in the development of innovative power generation systems. The company's flagship product, the PowerDish, is a proprietary solar power generation device that efficiently converts solar energy into electricity. Infinia also provides micro combined heat and power systems targeted at residential energy consumers, as well as solar and biomass-powered electric generators designed for various applications, including deep space missions and remote power needs. The PowerDish is aimed at energy asset developers, utilities, and commercial companies involved in large-scale solar projects, with a global launch anticipated to have begun in late 2010.

GlobeImmune, Inc. is a biopharmaceutical company based in Louisville, Colorado, specializing in the development of therapeutic products for cancer and infectious diseases utilizing its proprietary Tarmogen platform. Founded in 1995 as Ceres Pharmaceuticals, the company focuses on creating targeted molecular immunotherapies. Its product pipeline includes GS-4774, currently in Phase 2 trials for chronic hepatitis B infection, and GI-6301, aimed at cancers expressing the brachyury protein. Additionally, GlobeImmune is advancing GI-6207 for medullary thyroid cancer and GI-4000 for resected pancreatic cancer, with multiple Phase 2 clinical trials for various other cancers, including non-small cell lung cancer and colorectal cancer. The company is also developing several candidates targeting infectious diseases, including GI-19000 for tuberculosis, GI-2010 for HIV, and GI-18000 for hepatitis D, which are in preclinical stages. GlobeImmune has established strategic collaborations with notable organizations, enhancing its research and development efforts.

Interventional Spine, Inc. is dedicated to the design, development, production, and distribution of implantable devices for spinal surgery, catering to patients, surgeons, and hospitals globally. Founded in February 2000 and based in Irvine, California, the company addresses the challenges associated with treating osteoporotic bone, particularly in the aging population. Its product line includes the Opticage expandable interbody fusion device and the PERPOS PLS System, a compressible facet fixation system. The company’s innovative Compression (CLASP) technology enhances fracture fixation in both normal and osteoporotic bone, allowing for precise positioning and superior pullout resistance compared to traditional solutions. Interventional Spine originally focused on the podiatric and orthopedic trauma markets, successfully implanting over 4,000 orthopedic trauma products. As of January 2017, it operates as a subsidiary of DePuy Synthes, Inc., expanding its reach in the medical device industry.

Epiphany Biosciences, Inc. is a privately-held company based in San Francisco, California, focused on developing therapeutic products and diagnostic technologies to combat pathogenic viruses. The company specializes in creating antiviral therapeutics aimed at preventing the spread of viruses such as varicella zoster virus, Epstein-Barr virus, and hepatitis C virus. To advance its mission, Epiphany has assembled a team of experts in virology, clinical practice, and drug development, leveraging their extensive experience in the pharmaceutical industry. Through its innovative small molecule therapeutics platform, Epiphany aims to address significant public health challenges associated with viral infections.

ICx Technologies is a leader in the development and integration of advanced sensor technologies for homeland security, force protection and commercial applications. Their proprietary sensors detect and identify chemical, biological, radiological, nuclear and explosive threats, and deliver superior awareness and actionable intelligence for wide-area surveillance, intrusion detection and facility security. They then leverage their unparalleled technical expertise and government funding to address other emerging challenges of their time ranging from a cleaner environment, alternative energy to life science.

Tigris Pharmaceuticals, Inc., a biopharmaceutical company, develops therapeutic technologies for oncology and other areas of unmet medical need. Its products include Aminoflavone that is for the treatment of renal cell, breast, and lung cancer; GGTI-2418, a synthetic peptidomimetic inhibitor of geranylgeranyltransferase, which is for the treatment of lung, breast, pancreatic, and ovarian cancer; GFB-204, a calixarene derivative that is a potent and selective inhibitor of VEGFR and PDGFR tyrosine phosphorylation, which is for the treatment of prostate, pancreas, lung, breast, and renal cell. The company was founded in 2005 and is based in Bonita Springs, Florida.

Javelin Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of products for the pain management market primarily in the United States and Europe. Its products focus on treating various pain disorders ranging from acute and episodic moderate-to-severe pain associated with breakthrough cancer pain, post-operative pain, post-trauma pain (orthopedic injury pain), procedural pain, and burn pain. The company's Dyloject (injectable diclofenac) received approval for marketing to treat post-operative pain in the United Kingdom and was licensed to Therabel Pharma N.V. for commercialization in the European Union and certain other countries outside the United States. Its products in the Phase 3 development stage in the U.S. include Dyloject (diclofenac sodium injectable), an injectable formulation of diclofenac and a prescription nonsteroidal anti-inflammatory drug that is used to treat post-operative pain due to its combination of effectiveness and tolerability; Ereska (intranasal ketamine), a proprietary nasal formulation; and Rylomine (intranasal morphine) for treatment of acute moderate-to-severe pain, including breakthrough pain. Javelin Pharmaceuticals has license agreements with Shimoda Biotech, Ltd. to develop and commercialize products related to a proprietary formulation of the injectable delivery of diclofenac; and West Pharmaceutical Services, Inc. to develop and commercialize intranasal morphine for the transmucosal delivery of morphine to humans and animals for the treatment of pain. The company was founded in 1998 and is based in Cambridge, Massachusetts.

Encorp is a company focused on enhancing the distributed energy market through its innovative technologies and infrastructure management services. It specializes in energy automation software and grid interconnection equipment that facilitate the efficient control of various power resources, including engine-generator sets, microturbines, fuel cells, combined heat and power systems, and energy storage devices. By leveraging its advanced Gold Box technology, Encorp aims to transform the electric grid into a cleaner, more efficient, and reliable system. The company's solutions cater to federal, institutional, and commercial installations, enabling customers to achieve significant energy savings, enhance security, and reduce carbon emissions while maintaining high-quality and dependable power at predictable costs.

NxtPhase develops, manufactures, and markets optical sensor and digital solutions for the electric power industry. The company’s products include optical current and voltage sensors; and opto-electronic modules that provide signal processing electronics for voltage and current transducers. NxtPhase was founded in 1993 and is headquartered in Vancouver, Canada.